English | Español
Patient Daily | Jul 15, 2026

Biogen presents Phase 2 data on anti-tau therapy at Alzheimer’s conference
Patient Daily | Jul 15, 2026

Researchers develop AI model to predict immunotherapy outcomes for liver cancer patients
Patient Daily | Jul 15, 2026

Researchers report new drug candidate reduces Parkinson's dyskinesia in animal studies
Patient Daily | Jul 15, 2026

Ohio State program supports maternal health for postpartum women and children
Patient Daily | Jul 15, 2026

Lilly explores maintenance dosing for Kisunla after amyloid clearance in Alzheimer’s patients
Patient Daily | Jul 15, 2026

American Lung Association launches campaign to raise awareness of expanded access programs
Patient Daily | Jul 15, 2026

Pfizer ends development of Seagen antibody-drug conjugate for solid tumors
Patient Daily | Jul 15, 2026

Local teens join statewide summit to address tobacco industry influence

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'